Zobrazeno 1 - 10
of 99
pro vyhledávání: '"G C, Sutton"'
Autor:
MA de Belder, Rudy Bilous, J Carter, Neil Swanson, Scott Jones, James Mason, L. Thompson, Andrew J. Turley, David E. Newby, A G C Sutton, R Morley, Adetayo Kasim, Gareth J. Padfield, James A Hall, Nicholas L. Mills, Zulfiquar Adam, Robert A. Wright, Douglas F Muir
Publikováno v:
International journal of cardiology, 2016, Vol.216, pp.1-8 [Peer Reviewed Journal]
Background Stent design and technological modifications to allow for anti-proliferative drug elution influence restenosis rates following percutaneous coronary intervention (PCI). We aimed to investigate whether peri-procedural administration of cort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eac671af5a5ed5ebb11032e72d8afff
https://doi.org/10.1016/j.ijcard.2016.04.105
https://doi.org/10.1016/j.ijcard.2016.04.105
Autor:
Darragh Twomey, A G C Sutton, Douglas F Muir, Andrew J. Turley, Robert A. Wright, R Morley, Joel Dunning, Raj Das, James A Hall, Anthony P Roberts, Babu Kunadian, M A de Belder
Publikováno v:
Heart. 94:1012-1018
Objectives There is a pressing need for workable risk models for patients undergoing PCI. A few risk models have been proposed, but to be applicable to a national audit process, they must be validated not only on the local populations from which they
Autor:
Neil Swanson, David Austin, A G C Sutton, MA de Belder, R Morley, Robert A. Wright, Douglas F Muir, Muhammad Muzaffar Mahmood, J Carter, James A Hall, Paul D. Williams, MA Qureshi
Publikováno v:
Heart. 103:A22.2-A23
Introduction Rotational atherectomy (RA) during primary PCI (PPCI) for STEMI is relatively contraindicated because of the perceived increased risk of no-reflow. However, RA PPCI may sometimes be required to restore flow in heavily calcified coronary
Publikováno v:
International Journal of Cardiovascular Interventions. 4:15-20
BACKGROUND: The EPISTENT trial reported improved early outcomes with routine use of abciximab after coronary stenting. Increasing use of stents means that routine abciximab adds significantly to costs of percutaneous coronary intervention (PCI). This
Publikováno v:
European Heart Journal. 19:548-552
We would advocate 3 weeks of anticoagulation prior to, and 4 weeks post-cardioversion (either electrical or chemical) for patients in chronic atrial fibrillation or flutter. In selected cases it seems reasonable to use transoesophageal echocardiograp
Autor:
Paul D. Williams, J Carter, Robert A. Wright, James A Hall, David Austin, Neil Swanson, MA de Belder, Matthew Jackson, A G C Sutton, Douglas F Muir
Publikováno v:
Heart. 102:A13.3-A14
Introduction The RCTs, PRAMI1 and CVLPRIT,2 have suggested that preventative PCI for multi-vessel disease identified during PPCI improves outcomes with higher rates of cardiovascular events in the culprit-only cohorts. Methods 1143 consecutive STEMIs
Autor:
K, Mulligan, P A, Mehta, T, Fteropoulli, S W, Dubrey, H F, McIntyre, T A, McDonagh, G C, Sutton, D M, Walker, M R, Cowie, S, Newman
Publikováno v:
British journal of health psychology. 17(3)
This study sought to examine how patients' mood and quality of life (QoL) change during the early high-risk period after a diagnosis of heart failure (HF) and to identify factors that may influence change. A within-subjects, repeated-measures design
Autor:
Andrew G C, Sutton
Publikováno v:
Revista espanola de cardiologia. 64(11)
Autor:
R Morley, Zulfiquar Adam, Douglas F Muir, A G C Sutton, S. L. Hetherington, M A de Belder, Robert A. Wright, Neil Swanson, James A Hall
Publikováno v:
Heart (British Cardiac Society). 95(19)
To examine the safety and efficacy of emergency transradial primary percutaneous coronary intervention for ST-elevation myocardial infarction.Single-centre observational study with prospective data collection.A regional cardiac centre, United Kingdom